UMECRINE COGNITION AB has a total of 51 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are UNION INTERNATIONAL CO LTD, PANAGIN PHARMACEUTICALS INC and NOVELIX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Hungary | 4 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Israel | 3 | |
#8 | Republic of Korea | 3 | |
#9 | WIPO (World Intellectual Property Organization) | 3 | |
#10 | Brazil | 2 | |
#11 | Japan | 2 | |
#12 | Mexico | 2 | |
#13 | Serbia | 2 | |
#14 | Russian Federation | 2 | |
#15 | Argentina | 1 | |
#16 | Hong Kong | 1 | |
#17 | Montenegro | 1 | |
#18 | Taiwan | 1 | |
#19 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids | |
#4 | Climate change adaptation technologies | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Doverskog Magnus | 22 |
#2 | Ragagnin Gianna | 20 |
#3 | Bäckström Torbjörn | 18 |
#4 | Felipo Vicente | 13 |
#5 | Backstrom Torbjorn | 10 |
#6 | Johansson Maja | 9 |
#7 | Meijer Thomas | 8 |
#8 | Schipper Nicolaas | 8 |
#9 | Alhadeff Paul | 8 |
#10 | Möhler Hanns | 7 |
Publication | Filing date | Title |
---|---|---|
AU2018374029A1 | Pharmaceutical formulation of 3a-ethynyl-3B-hydroxyandrostan-17-one oxime | |
US2017348323A1 | Methods for treating hypersomnolence | |
TW201639579A | Novel compounds | |
CN106163528A | For treating the steroid of liver encephalopathy |